AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Astrazeneca stock last closed at $68.47, up 0.19% from the previous day, and has increased 24.97% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.01 percentage points. Astrazeneca stock is currently +30.05% from its 52-week low of $52.65, and -4.5% from its 52-week high of $71.70.
There are currently 1.55B AZN shares outstanding. The market cap of AZN is $211.98B. In the last 24 hours, 3.53M AZN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy AZN shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now.Open eToro Account
Now that you've selected your brokerage, you'll need to fill out some personal details so you can invest in AZN today.
Check out this video walkthrough if you need help transferring money into your brokerage account.
It's critical to analyze stocks before you buy, so you actually wrap your head around the risk as well as the upside.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on AZN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge AZN's intrinsic value.
Using relative valuations measures:
You can access additional valuation analysis on AZN's stock here.
Out of 4 Equities analysts who monitor AZN, the consensus analyst rating on Astrazeneca is a Buy
Andrew Berens, a bottom 3% analyst from SVB Leerink maintains AZN with a buy rating and raises their AZN price target from $78.00 to $79.00, on Nov 14, 2022.
John Eade, a top 12% analyst from Argus Research upgrades AZN to a strong buy rating and announces their AZN price target of $75.00, on Aug 29, 2022.
Elmar Kraus, a top 29% analyst from DZ Bank upgrades AZN to a hold rating, on Feb 11, 2022.
Peter Welford, a bottom 23% analyst from Jefferies downgrades AZN to a hold rating, on Dec 7, 2021.
You can dig deeper into what analysts are forecasting on the Astrazeneca stock forecast page.
Last year, AZN earnings were $2.04B. Over the past 5 year, AZN's earnings have gone up by -16.89% per year. This was slower than the Drug Manufacturers - General industry average of 14.45%.
Last year, AZN revenue was $45.15B. In the last 5 year, AZN's revenue has increased by 15.18% per year. This was faster than the Drug Manufacturers - General industry average of 8.2%.
Find out more about AZN's earnings and revenue performance here.
Over the past year, executives and large shareholders at AZN have not bought or sold any shares.
Learn more about who owns AZN shares here.
Astrazeneca pays a dividend of 2.12%, compared to the Drug Manufacturers - General industry's average dividend yield of 3%. If you owned $1,000 of AZN stock, you would have received $21.18 in the past 12 months.
Astrazeneca dividend payments have not consistently grown over the past decade and have not remained stable.
Dig into more analysis about Astrazeneca dividend yield and history here.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two main order types:
Click the Open button and your broker will place your order.
If you require more info about buying stocks on eToro, click the how to video below:
Now that you own some AZN shares, you'll want to keep up with your shares.
Put AZN on a watchlist to get notified of important updates regarding your AZN stock.
To summarize, here are the 6 steps for buying Astrazeneca stock:
If you require a online brokerage, eToro is our favorite venue.Get Started with eToro Today
If you want to get the latest scoop on your new investment in Astrazeneca, add AZN to your watchlist below.
How much does it cost to buy one Astrazeneca share?
Is now a good time to buy Astrazeneca stock?
What is the best way to buy Astrazeneca stock?